Management of infection risk to myeloma patients during the COVID pandemic Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria 1 Oct 2020
Lenalidomide combination for multiple myeloma Prof Xavier Leleu - Hôpital La Mileterie CHU, Poitiers, France 1 Oct 2020
Mass spectrometry for the detection of minimal residual disease (MRD) in myeloma Dr Noemí Puig - Hospital Universitario de Salamanca, Salamanca, Spain 25 Sep 2020
Managing multiple myeloma in a COVID-19 world Prof Mohamad Mohty - Saint-Antoine Hospital, Paris, France 25 Sep 2020